Winfield Associates’s Merck MRK Stock Holding History

Winfield Associates’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,123	Closed	-$61K	–	437
2017 Q4	$61K	Buy	1,123 +70	+7%	+$3.88K	0.03%	187
2017 Q3	$64K	Buy	1,053 +3	+0.3%	+$182	0.03%	178
2017 Q2	$64K	Buy	1,050 +167	+19%	+$10.2K	0.04%	175
2017 Q1	$54K	Sell	883 -135	-13%	-$8.19K	0.03%	181
2016 Q4	$57K	Buy	1,018 +360	+55%	+$21.1K	0.04%	173
2016 Q3	$39K	Hold	658	–	–	0.02%	193
2016 Q2	$37K	Buy	658 +115	+21%	+$6.12K	0.02%	195
2016 Q1	$27K	Buy	543 +241	+80%	+$11.8K	0.02%	209
2015 Q4	$15K	Hold	302	–	–	0.01%	230
2015 Q3	$14K	Hold	302	–	–	0.01%	229
2015 Q2	$16K	Hold	302	–	–	0.01%	208
2015 Q1	$17K	Hold	302	–	–	0.01%	211
2014 Q4	$16K	Hold	302	–	–	0.01%	214
2014 Q3	$17K	Sell	302 -203	-40%	-$11.4K	0.01%	210
2014 Q2	$27K	Buy	505 +1	+0.2%	+$55	0.02%	194
2014 Q1	$27K	Buy	+504	New	+$26.1K	0.02%	184

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Winfield Associates's MRK Position: Q1 2018 in Review

Winfield Associates sold out of Merck (MRK) in Q1 2018, closing a stake of 1,123 shares — an estimated $61K sold.

Winfield Associates first reported a position in MRK in Q1 2014 and held it in 16 quarters. The position peaked at $64K in Q3 2017. 1,992 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

Winfield Associates reported no remaining Merck position as of Q1 2018 after selling out during the quarter.
Winfield Associates sold 1,123 Merck shares in Q1 2018, an estimated $61K.
Winfield Associates first reported a position in Merck in Q1 2014 and held it in 16 quarters.
Winfield Associates's Merck position peaked at $64K in Q3 2017.
1,992 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.